Tonix Pharmaceuticals Holding Corp. (TNXP)
Company Info
Highlights
$55.90M
-$8.04K
$7.51M
$930.00K
-$53.33M
$9.72 - $1,244.80
$583.33
1.74%
0.09
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Tonix Pharmaceuticals Holding Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Tonix Pharmaceuticals Holding Corp. had a return of -69.68% year-to-date (YTD) and -99.16% in the last 12 months. Over the past 10 years, Tonix Pharmaceuticals Holding Corp. had an annualized return of -68.46%, while the S&P 500 had an annualized return of 11.31%, indicating that Tonix Pharmaceuticals Holding Corp. did not perform as well as the benchmark.
TNXP
-69.68%
-57.54%
-72.22%
-99.16%
-87.13%
-68.46%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of TNXP, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 29.81% | -69.68% | |||||||||||
| 2024 | -20.60% | 18.19% | -50.82% | -3.55% | -9.20% | -86.62% | -28.86% | -53.84% | -35.15% | -2.15% | 30.56% | 73.85% | -97.44% |
| 2023 | 187.33% | -37.50% | -15.56% | -12.03% | -44.92% | -11.73% | -32.28% | -9.68% | -43.61% | 8.26% | -12.20% | -22.20% | -83.46% |
| 2022 | -32.07% | -23.91% | 24.50% | -36.62% | -47.74% | -35.25% | 6.33% | -39.29% | -47.63% | -15.57% | -14.63% | 1.25% | -96.59% |
| 2021 | 44.98% | 21.60% | 7.56% | -10.94% | 3.51% | -5.93% | -35.50% | -1.41% | -14.85% | -8.17% | -15.00% | -23.76% | -47.01% |
| 2020 | 19.66% | -22.86% | -34.26% | -5.17% | -3.46% | -6.08% | 111.30% | -31.38% | -5.11% | -33.11% | 8.76% | 10.46% | -42.31% |
| 2019 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -27.68% | 3.54% | -25.12% |
| 2018 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TNXP is 9, meaning it’s performing worse than 91% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Tonix Pharmaceuticals Holding Corp. (TNXP) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Tonix Pharmaceuticals Holding Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tonix Pharmaceuticals Holding Corp. was 100.00%, occurring on Feb 19, 2025. The portfolio has not yet recovered.
The current Tonix Pharmaceuticals Holding Corp. drawdown is 100.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Feb 28, 2020 | 1251 | Feb 19, 2025 | — | — | — |
| -74.12% | Feb 6, 2020 | 13 | Feb 25, 2020 | 2 | Feb 27, 2020 | 15 |
| -42.19% | Nov 18, 2019 | 16 | Dec 10, 2019 | 18 | Jan 7, 2020 | 34 |
| -16.16% | Jan 17, 2020 | 3 | Jan 22, 2020 | 2 | Jan 24, 2020 | 5 |
| -15.52% | Jan 28, 2020 | 3 | Jan 30, 2020 | 3 | Feb 4, 2020 | 6 |
Volatility
Volatility Chart
The current Tonix Pharmaceuticals Holding Corp. volatility is 98.61%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Tonix Pharmaceuticals Holding Corp..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |